Fund Family SBI Mutual Fund
Fund Class Sector - Pharma & Healthcare
Not Ranked
This scheme is not ranked by CRISIL.
View Top ranked funds in other categories
| Period | Returns (%) | Rank # |
|---|---|---|
| 1 mth | -1.4 | 1 |
| 3 mth | 7.8 | 1 |
| 6 mth | 10.3 | 1 |
| 1 year | 10.3 | 1 |
| 2 year | 12.7 | 1 |
| 3 year | 25.5 | 2 |
| 5 year | 6.6 | 3 |
# Moneycontrol Rank within 3 Sector - Pharma & Healthcare Schemes.
| Year | Qtr 1 | Qtr 2 | Qtr 3 | Qtr 4 | Annual |
|---|---|---|---|---|---|
| 2012 | 9.4 | - | - | - | - |
| 2011 | -6.1 | 6.8 | -8.3 | 2.9 | -5.6 |
| 2010 | 4.8 | 9.8 | -0.3 | 9.5 | 29.8 |
| 2009 | -11.1 | 43.8 | 26.2 | -0.2 | 81.4 |
| 2008 | -27.0 | 6.7 | -10.5 | -27.8 | -50.2 |
| 2007 | -7.2 | 12.9 | -9.7 | 11.7 | 5.7 |
* Returns over 1 year are Annualised
Fund returns v/s Category average (Sector - Pharma & Healthcare)
| 1 mth (%) | 3 mth (%) | 6 mth (%) | 1 yr (%) | 2 yr (%) | 3 yr (%) | 5yr (%) | |
| Fund Returns | -1.4 | 7.8 | 10.3 | 10.3 | 12.7 | 25.5 | 6.6 |
| Category avg | -2.3 | 5.8 | 7.2 | 5.1 | 9.8 | 27.1 | 12.9 |
| Difference of Fund returns and Category returns | 0.9 | 2.0 | 3.1 | 5.2 | 2.9 | -1.6 | -6.3 |
| Best of category | -1.4 | 7.8 | 10.3 | 10.3 | 12.7 | 31.8 | 19.9 |
| Worst of category | -2.8 | 3.5 | 3.1 | 1.5 | 7.9 | 23.9 | 6.6 |
| Benchmark returns # | -1.5 | 5.7 | 10.9 | 6.4 | 11.3 | 24.2 | 12.0 |
| Difference of Fund returns and Benchmark returns | 0.1 | 2.1 | -0.6 | 3.9 | 1.4 | 1.3 | -5.4 |
Investment Objective
To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy. There are five sub-funds dedicated to specific investment themes viz.Information Technology, Pharmaceuticals,FMCG, Contrarian (investment in stocks currently out of favour) and Emerging Businesses.
| Fund Type | Open-Ended |
|---|---|
| Investment Plan | Dividend |
| Launch date | Jul 31, 1999 |
| Benchmark | BSE HEALTHCARE |
| Asset Size (Rs cr) | 41.05 (Mar-31-2012) |
| Minimum Investment | Rs.2000 |
| Last Dividend | Rs.3.90 (Dec-31-2004) View Dividend History |
| Bonus | N.A. |
| Fund Manager | Tanmaya Desai View performance of schemes managed by the Fund Manager |
| Notes | N.A |
| Entry Load | N.A |
|---|---|
| Exit Load | 1.00% |
| Load Comments | Exit Load 1% if units are redeemed / switched-out within 1 year from the date of allotment. |
| Regd. Office | 191 Maker Towers E, Cuffe Parade, Mumbai, 400005 |
|---|---|
| Tel. No. | 91 22 22180221/ 27 |
| Fax No. | 91 22 22189663 |
| partnerforlife@sbimf.com | |
| Website | http://www.sbimf.com |
| Sector - Pharma & Healthcare | Crisil Rank | Assets (Rs.cr) |
|||||
| 3mth (%) | 6mth (%) | 1yr (%) | 3yr (%) | 5yr (%) | |||
| Reliance Pharma Fund (G) | Not Ranked |
563.56 | 6.0 | 8.1 | 3.4 | 31.8 | 19.9 |
| SBI Magnum Pharma Fund (G) | Not Ranked |
41.05 | 7.8 | 10.3 | 10.3 | 25.5 | 6.6 |
| UTI Pharma & Health (G) | Not Ranked |
93.37 | 3.5 | 3.1 | 1.5 | 23.9 | 12.3 |
| * Returns over 1 year are Annualised | More » | ||||||
| Equity | Sector | Value (Rs cr) |
Asset % |
|---|---|---|---|
| Dr Reddys Labs | Pharmaceuticals | - | 14.31 |
| Cipla | Pharmaceuticals | - | 10.86 |
| Divis Labs | Pharmaceuticals | - | 9.94 |
| Lupin | Pharmaceuticals | - | 9.87 |
| Cadila Health | Pharmaceuticals | - | 8.96 |
| Ipca Labs | Pharmaceuticals | - | 7.02 |
| Torrent Pharma | Pharmaceuticals | - | 6.79 |
| Wyeth | Pharmaceuticals | - | 6.26 |
| Sun Pharma | Pharmaceuticals | - | 4.90 |
| Novartis India | Pharmaceuticals | - | 3.28 |
| Sector | % | 1-Year HighLow |
|
|---|---|---|---|
| Pharmaceuticals | 94.25 | 98.60 | 90.13 |
| Equity | 94.25 |
| Others | 0.00 |
| Debt | 0.00 |
| Mutual Funds | N.A |
| Money Market | 0.00 |
| Cash / Call | 5.75 |
| Holdings | (%) |
|---|---|
| Top 5 | 53.94 |
| Top 10 | 82.19 |
| Sector | (%) |
|---|---|
| Top 3 | 94.25 |
SBI MF announces change in benchmark of Magnum COMMA Fund
SBI Mutual Fund has announced change in benchmark of Magnum COMMA Fund from BSE 200 to CNX Commoditi ...
Mar 31, 2012 at 16:00 | Source: Moneycontrol.com
NAVs slips as market ends in a negative terrain
Equity funds couldn’t sustain its two days of gaining streak and finally succumb under market pressu ...
Mar 02, 2012 at 9:35 | Source: Moneycontrol.com
SEBI brings in to action the new KYC process
Effective January 1, 2012, all AMCs will adhere to the new KYC process implemented by SEBI to bring ...
Jan 03, 2012 at 16:42 | Source: Moneycontrol.com
Oct 25, 2011
Oct 25, 2011
Oct 25, 2011
Quick Links